Expansion of business areas beyond contact lenses

「In the healthcare field, we focused on the peptide sector and obtained medical device approval for a bone-filling material while developing new products.」

「In the animal healthcare business, we expanded the product lineup of intraocular lenses for dogs and prepared for their launch.」

「During the current fiscal year, we reviewed our business portfolio from the perspective of capital efficiency for businesses where improving profitability is difficult. We will continue reviewing the business portfolio to improve future returns on capital while pursuing initiatives to create new businesses that could become a second pillar.」

「As part of efforts to expand businesses that reduce environmental impact, we began producing Naru-O Turf, an improved Japanese turfgrass variety, as a new product contributing to environmental greening, and worked to expand the healthcare and lifecare businesses by entering the green infrastructure business.」

「In the animal healthcare business, to expand sales channels for dog and cat supplements, we began selling to general consumers in addition to sales to veterinary clinics and veterinary pharmaceutical wholesalers. In the supplement business, we worked aggressively to expand sales by adding new products focused on the healthcare field, including femtech-related products.」

「In the food and composting-related businesses, we worked to expand sales channels, mainly overseas. In the animal healthcare business, to expand sales channels for dog and cat supplements, we began selling to general consumers in addition to sales to veterinary clinics and veterinary pharmaceutical wholesalers. In the supplement business, we worked aggressively to expand sales by adding new products focused on the life support field, including femtech-related products.」

「In the food and composting-related businesses, we worked to expand sales channels, mainly overseas. In the food business, we continued sales activities focused primarily on Japanese-made products in Asia, and sales grew steadily. In the supplement business, we added new products focused on the life support field, including femtech-related products, and worked aggressively to expand sales. As a result, sales in the other businesses, driven mainly by increased overseas food sales, were ¥5,088 million, up 39.9% year on year.」

「In the food and composting-related businesses, we worked to expand sales channels, mainly overseas. In the food business, we strengthened our sales structure to expand sales in China, resulting in sales, primarily of Japanese-made products.」

「Sales in the other businesses increased 30.7% year on year.」

「As part of the core service Dog Mirai Hosho of &D (アンド・ディー), we opened &HAUS (アンド・ハウス) in Kasama, Ibaraki Prefecture. The facility manages a service that takes in dogs that can no longer live with their owners and provides lifelong care or transfers them to new owners.」

「In overseas markets, the food business drove sales, while we also worked to expand overseas sales channels for resQ composting accelerator materials and the animal healthcare business.」

「In the life support business, we focused on expanding sales of Miglis, a device for selecting motile sperm, and the Pregna series of supplements supporting fertility, in response to the expansion of the fertility market following the inclusion of fertility treatment in Japan's public health insurance coverage from April 2022. In the environmental and biotechnology business, overseas sales of resQ composting accelerator materials and other products drove revenue. In the animal healthcare and coexistence business, 株式会社メニワン began selling Menicon Wan Corneal Bandage Wan, a contact lens for dogs and cats, in Thailand, while also working to expand overseas sales channels.」

「Including the contribution from the food business of the Itabashi Boeki Group, which became a wholly owned subsidiary in January 2021, sales in the other businesses increased 288.8% year on year.」

「During the consolidated accounting period, we launched Dog Mirai Hosho, the core service of &D (アンド・ディー), a new business established to promote coexistence between people and dogs and support the happiness of all dogs. We also began selling Meni Supplement Dietary Fiber Inulin + Lactic Acid Bacteria. In the Itabashi Boeki Group, which became a wholly owned subsidiary in the previous consolidated fiscal year, we are expanding export channels for the food business.」

「In the Itabashi Boeki Group, which became a wholly owned subsidiary in the previous consolidated fiscal year, we are expanding export channels for the food business.」

「During the consolidated accounting period, we launched &D (アンド・ディー), a new service that contributes to addressing social issues through services supporting rich lives with companion dogs, based on a business model designed to promote coexistence between people and dogs and support dogs' happiness.」

「Through bold efforts to take on new products and services, our group aims to develop the other businesses into a second business base and will pursue expansion with overseas markets also in view.」

「In the life sciences business, we newly launched 2 foods with function claims under the Meni Supplement series to improve users' quality of life through the brand. In addition, 株式会社メニコンネクト newly launched Metome Care Cleansing Gel, a skin-friendly cleanser that combines gentleness to the eyes with cleansing power, based on research cultivated over many years through the development of contact lenses and care products.」

「In 株式会社メニワン's animal healthcare business, we launched Clear View 2, a veterinary fundus camera. Used together with Fundus AI, an AI-based ophthalmic examination support service for veterinarians treating dogs that has already been released, the camera can assist in the early detection and treatment of canine eye diseases.」

「Specifically, we prepared to launch Iris Vet light, an examination instrument, and Clear View 2, a fundus camera, as veterinary medical equipment, as well as Vegetable Support Doctor Plus Glutamine & Oligo, a supplement.」

「At 株式会社メニワン, we launched Fundus AI (ファンダスアイ), an ophthalmic examination support service for veterinarians treating dogs, in October. We believe the service will greatly assist veterinary ophthalmic examinations and the early detection and treatment of canine eye diseases. In the life sciences business, we also began offering Plarie (プラリエ), a placenta extract-containing supplement for women's nutrition, beauty and fertility support, through an online shop.」

「At 株式会社メニワン, we worked to expand sales of supplements in addition to the animal healthcare and medical equipment businesses. In the life sciences business, we launched Menicon's first supplement classified as a food with function claims, Meni Supplement Bilberry, in August. It supports visual adjustment function and alleviates eye fatigue.」

「Our environmental biotechnology business grew through the expansion of the composting accelerator business. In the life sciences business, we renewed the Pregna series of supplements that support fertility and are also working to expand sales of lactoferrin-based supplements designed to support the eyes and various life stages.」

「In the life sciences business, we renewed the Pregna series of supplements that support fertility and will work to expand sales together with lactoferrin-based supplements developed around the concept of supporting the eyes.」

「Sales remained solid for veterinary medical equipment and dog and cat supplements at group company 株式会社メニワン, as well as composting accelerators in our environmental biotechnology business. In addition, our life sciences business sells supplements that support fertility and supplements whose main ingredient is lactoferrin.」

「Sales remained solid for veterinary medical equipment and dog and cat supplements at group company 株式会社メニワン, as well as composting accelerators in our environmental biotechnology business. In addition, our life sciences business sells fertility-support supplements and supplements whose main ingredient is lactoferrin.」

「In addition to veterinary medical equipment and dog and cat supplements, group company 株式会社メニワン has been steadily increasing sales of Perowan, an oral care supplement launched last year. Our environmental biotechnology business continued to post solid sales of rice-straw decomposition accelerators. In addition, our life sciences division sells fertility-support supplements and supplements whose main ingredient is lactoferrin.」

「Sales remained solid for veterinary medical equipment and dog and cat supplements at group company 株式会社メニワン, as well as rice-straw decomposition accelerators in our environmental biotechnology business. In addition, our life sciences division sells fertility-support supplements and supplements whose main ingredient is lactoferrin.」

「Sales remained solid for veterinary medical equipment and dog and cat supplements at group company 株式会社メニワン, as well as rice-straw decomposition accelerators in our environmental biotechnology business. In addition, our life sciences division sells fertility-support supplements and supplements whose main ingredient is lactoferrin.」

「In the animal healthcare business, group company 株式会社メニワン continued to post solid sales of intraocular lenses, ophthalmic medical equipment and ophthalmic supplements. It has also entered fields outside ophthalmology, such as supplements for the liver and intestines and oral care supplements, expanding its sales channels.」

「We renewed the Menicon Wan Eye series of dog supplements, which has been well received since its launch, added new ingredients and began selling the Menicon Wan Eye II series of dog and cat supplements. In the environmental biotechnology business, sales remained solid for resQ45, a composting accelerator for livestock manure, and Agri Kakumei, a rice-straw decomposition accelerator. In the life sciences business, we began selling LaferriEye (ラフェリアイ), a supplement designed to help restore the mind and body fatigued by modern life, through our company-operated stores nationwide. Going forward, we will work to expand sales through new proposals for products used in in vitro fertilization as part of fertility treatment.」

「In the life sciences business, we sell LaferriEye (ラフェリアイ) as a supplement designed to help restore the mind and body fatigued by modern life, and have decided to sell it at our company-operated stores nationwide. We are also working to expand sales through new proposals for products used in in vitro fertilization as part of fertility treatment.」

「In businesses other than contact lenses, sales remained solid for veterinary medical equipment and dog and cat supplements in the animal healthcare business, as well as composting accelerators in our environmental biotechnology business. In addition, supplements for fertility support and other products in the life sciences business performed well.」